Prolonged treatment free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
File(s)TFR after BCR-ABL mutations 03_01_19.docx (269.08 KB)
Accepted version
Author(s)
Claudiani, Simone
Apperley, Jane F
Khan, Afzal
Khorashad, Jamshid S
Milojkovic, Dragana
Type
Journal Article
Date Issued
2020-05-01
Date Acceptance
2019-09-19
Citation
Haematologica: the hematology journal, 2020, 105, pp.e225-e227
ISSN
0390-6078
Publisher
Ferrata Storti Foundation
Start Page
e225
End Page
e227
Journal / Book Title
Haematologica: the hematology journal
Volume
105
Copyright Statement
© 2019, Ferrata Storti Foundation.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31537692
PII: haematol.2019.234179
Subjects
Chronic Myelogenous Leukemia
Hematopoietic Stem Cell
Leukemic Stem Cell
treatment free remission
tyrosine kinase inhibitors
Publication Status
Published
Coverage Spatial
Italy
Date Publish Online
2019-09-19